Pharmacogenomic (PGx) Panel

The Fagron Pharmacogenomic (PGx) Panel is a transformative genetic test that revolutionizes medication management by revealing how your body responds to drugs, ensuring safer and more effective treatments. Using a simple, non-invasive cheek swab, this test analyzes key single nucleotide polymorphisms (SNPs) related to drug metabolism, efficacy, and potential side effects across multiple medication classes, conducted in a certified laboratory. The comprehensive report is delivered within 5 to 7 business days after it's received at the lab, accessible via a secure online portal.

For those facing challenges with medication side effects or ineffective treatments, this panel offers a personalized path to optimized therapy. By identifying genetic variations that affect how your body processes medications, the test enables healthcare providers to tailor prescriptions, dosages, and treatment plans to minimize adverse reactions and maximize effectiveness. This science-driven approach empowers you to achieve better health outcomes with confidence, using a customized strategy that aligns with your unique genetic profile.

Why Choose This Panel?
Choose the Pharmacogenomic (PGx) Panel if you’re concerned about medication effectiveness or side effects across various health conditions. Unlike the Chronic Pain Panel, which focuses on pain management, or the Neurological Psych Panel, which targets mental health, this panel broadly optimizes medication response for multiple drug classes, making it ideal for those on multiple medications or with complex treatment needs.